We have previously showed that oridonin targets c-Myc oncoprotein for degradation in an Fbw7-mediated manner16 and that by inhibiting c-Myc-regulated microRNAs, oridonin reverses chemoresistance in leukemia cells17. This evidence concerns the gene MYC and leukemia.